Close Window

Digital Look Email A Friend

FDA accepts Angle's review submission for Parsortix PC1

Published by Josh White on 20th October 2020

(Sharecast News) - Liquid biopsy company Angle announced on Tuesday that the US Food and Drug Administration (FDA) has completed its administrative review, and accepted the company's submission for substantive review.

URL: http://www.digitallook.com/dl/news/story/31327036/...

Email this article to your friends
NOTE: These email addresses will be used to email the information on your behalf and will not be collected by Digital Look for any marketing purposes.